Kendra N. Avery

679 total citations
26 papers, 217 citations indexed

About

Kendra N. Avery is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Kendra N. Avery has authored 26 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 16 papers in Oncology and 12 papers in Immunology. Recurrent topics in Kendra N. Avery's work include Monoclonal and Polyclonal Antibodies Research (20 papers), CAR-T cell therapy research (11 papers) and Immune Cell Function and Interaction (7 papers). Kendra N. Avery is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), CAR-T cell therapy research (11 papers) and Immune Cell Function and Interaction (7 papers). Kendra N. Avery collaborates with scholars based in United States and Japan. Kendra N. Avery's co-authors include Raymond E. Schaak, John C. Williams, K.P. Bzymek, David Horne, Cindy Zer, Joshua Donaldson, Christine Bonzon, Rumana Rashid, Gregory L. Moore and Yuelong Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Kendra N. Avery

26 papers receiving 203 citations

Peers

Kendra N. Avery
Martin Schwill Switzerland
Mariangela Spitali United Kingdom
Thomas Hey Germany
Ankit Gupta United States
Atrish Bagchi United States
Ai Ching Lim United States
Evelina Edelweiss Russia
Yuri V. Khramtsov Russia
Martin Schwill Switzerland
Kendra N. Avery
Citations per year, relative to Kendra N. Avery Kendra N. Avery (= 1×) peers Martin Schwill

Countries citing papers authored by Kendra N. Avery

Since Specialization
Citations

This map shows the geographic impact of Kendra N. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kendra N. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kendra N. Avery more than expected).

Fields of papers citing papers by Kendra N. Avery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kendra N. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kendra N. Avery. The network helps show where Kendra N. Avery may publish in the future.

Co-authorship network of co-authors of Kendra N. Avery

This figure shows the co-authorship network connecting the top 25 collaborators of Kendra N. Avery. A scholar is included among the top collaborators of Kendra N. Avery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kendra N. Avery. Kendra N. Avery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Robyn, Dionysos Slaga, Kendra N. Avery, et al.. (2024). IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion. Molecular Cancer Therapeutics. 23(9). 1305–1316. 5 indexed citations
2.
Moore, Gregory L., Juan E. Diaz, Christine Bonzon, et al.. (2024). A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti–PD-1 and CD3 T-cell Engager Immunotherapies. Molecular Cancer Therapeutics. 24(3). 331–344. 11 indexed citations
3.
Wakefield, Devin L., Ottavia Golfetto, Kendra N. Avery, et al.. (2023). Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands. Frontiers in Medicine. 10. 1064242–1064242. 3 indexed citations
4.
Tanaka, Hiroaki, Rumana Rashid, Kendra N. Avery, et al.. (2023). Abstract 2962: ASP2138, a novel 2+1 format, claudin 18.2 x CD3 bispecific antibody, demonstrates selectivity and activity in preclinical cancer models. Cancer Research. 83(7_Supplement). 2962–2962. 7 indexed citations
5.
Nisthal, Alex, Sung‐Hyung Lee, Christine Bonzon, et al.. (2022). 1372 XmAb143, an engineered IL18 heterodimeric Fc-fusion, features improved stability, reduced potency, and insensitivity to IL18BP. Regular and Young Investigator Award Abstracts. A1426–A1426. 3 indexed citations
6.
Zhang, Tian, Matthew S. Faber, Erik Pong, et al.. (2022). 1067 Synergistic combination of natural killer cell engagers (NKEs) with proinflammatory cytokines. Regular and Young Investigator Award Abstracts. A1109–A1109. 2 indexed citations
7.
Moore, Gregory L., Juan E. Diaz, Christine Bonzon, et al.. (2021). 698 PD-L1 targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors. SHILAP Revista de lepidopterología. A726–A726. 1 indexed citations
8.
Moore, Gregory L., Juan E. Diaz, Christine Bonzon, et al.. (2021). Abstract 1880: PDL1-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors. Cancer Research. 81(13_Supplement). 1880–1880. 1 indexed citations
9.
Nisthal, Alex, Matthew A. Dragovich, Erik Pong, et al.. (2020). Abstract 5663: Affinity tuned XmAb®2+1 PSMA x CD3 bispecific antibodies demonstrate selective activity in prostate cancer models. Cancer Research. 80(16_Supplement). 5663–5663. 1 indexed citations
10.
Nisthal, Alex, Sung‐Hyung Lee, Yoon Kyung Kim, et al.. (2020). Abstract 2286: XmAb30819, an XmAb®2+1 ENPP3 x CD3 bispecific antibody for RCC, demonstrates safety and efficacy in in vivo preclinical studies. Cancer Research. 80(16_Supplement). 2286–2286. 5 indexed citations
11.
Golfetto, Ottavia, Devin L. Wakefield, Kendra N. Avery, et al.. (2018). A Platform To Enhance Quantitative Single Molecule Localization Microscopy. Journal of the American Chemical Society. 140(40). 12785–12797. 25 indexed citations
12.
Bzymek, K.P., James W. Puckett, Cindy Zer, et al.. (2018). Mechanically interlocked functionalization of monoclonal antibodies. Nature Communications. 9(1). 1580–1580. 11 indexed citations
13.
Varma, Rajat, Ke Liu, Kendra N. Avery, et al.. (2018). Regulatory T Cell Selective IL-2-Fc Fusion Proteins for the Treatment of Autoimmune Diseases. Blood. 132(Supplement 1). 3709–3709. 3 indexed citations
14.
Hedvat, Michael, Christine Bonzon, Matthew J. Bernett, et al.. (2018). Abstract 2784: Simultaneous checkpoint-checkpoint or checkpoint-costimulatory receptor targeting with bispecific antibodies promotes enhanced human T cell activation. Cancer Research. 78(13_Supplement). 2784–2784. 7 indexed citations
15.
Bernett, Matthew J., Rajat Varma, Christine Bonzon, et al.. (2018). Abstract 5565: Potency-reduced IL15/IL15Rα heterodimeric Fc-fusions display enhanced in vivo activity through increased exposure. Cancer Research. 78(13_Supplement). 5565–5565. 10 indexed citations
16.
Bzymek, K.P., Yuelong Ma, Kendra N. Avery, David Horne, & John C. Williams. (2017). Meditope–Fab interaction: threading the hole. Acta Crystallographica Section F Structural Biology Communications. 73(12). 688–694. 2 indexed citations
17.
Bernett, Matthew J., Christine Bonzon, Rumana Rashid, et al.. (2017). Abstract 1595: IL15/IL15Rα heterodimeric Fc-fusions with extended half-lives. Cancer Research. 77(13_Supplement). 1595–1595. 1 indexed citations
18.
Avery, Kendra N., Cindy Zer, K.P. Bzymek, & John C. Williams. (2015). Development of a High Affinity, Non-covalent Biologic to Add Functionality to Fabs. Scientific Reports. 5(1). 7817–7817. 5 indexed citations
19.
Donaldson, Joshua, Cindy Zer, Kendra N. Avery, et al.. (2013). Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies. Proceedings of the National Academy of Sciences. 110(43). 17456–17461. 42 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Schwill Breakdown of academic impact, for papers by Mariangela Spitali Breakdown of academic impact, for papers by Thomas Hey Breakdown of academic impact, for papers by Ankit Gupta Breakdown of academic impact, for papers by Atrish Bagchi Breakdown of academic impact, for papers by Ai Ching Lim Breakdown of academic impact, for papers by Evelina Edelweiss Breakdown of academic impact, for papers by Yuri V. Khramtsov
Rankless by CCL
2026